NRD
DVAX

Nebula Research & Development’s Dynavax Technologies DVAX Stock Holding History

Nebula Research & Development’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,599
Closed -$145K – 276
2025
Q2 		$145K Buy
+14,599
New +$154K 0.01% 908

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Nebula Research & Development's DVAX Position: Q3 2025 in Review

Nebula Research & Development sold out of Dynavax Technologies (DVAX) in Q3 2025, closing a stake of 14,599 shares — an estimated $145K sold.

Nebula Research & Development first reported a position in DVAX in Q2 2025 and held it in 1 quarter. The position peaked at $145K in Q2 2025. 270 funds tracked by Wall St. Rank hold DVAX as of Q3 2025.

  • Nebula Research & Development reported no remaining Dynavax Technologies position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 14,599 Dynavax Technologies shares in Q3 2025, an estimated $145K.
  • Nebula Research & Development first reported a position in Dynavax Technologies in Q2 2025 and held it in 1 quarter.
  • Nebula Research & Development's Dynavax Technologies position peaked at $145K in Q2 2025.
  • 270 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.